FDA Adverse Event Other Summary report: N

INVISALIGN SYSTEM

MDR report key: 2020239 · Received March 9, 2011

Report

Report Number
2953749-2011-00028
Event Type
Other
Date Received
March 9, 2011
Date of Event
August 1, 2010
Report Date
February 28, 2011
Manufacturer
ALIGN TECHNOLOGY, INC.
Product Code
NXC
PMA / PMN Number
K981095
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
DENTIST

Narratives

Additional Manufacturer Narrative · 1

THE ALIGNERS ARE NOT BEING EVALUATED AS THE PRODUCT PERFORMED IN ACCORDANCE TO SPECIFICATIONS AND THE DEVICE WAS USED IN ACCORDANCE WITH LABEL INDICATIONS. THE TREATING PHYSICIAN BELIEVES THAT THIS COULD HAVE BEEN A MILD ANAPHYLACTIC REACTION, MEDICATION WAS TAKEN BY THE PT TO ALLEVIATE THE REPORTED SYMPTOMS. WITHOUT ADDITIONAL MEDICAL TREATMENTS, INFO OR TESTING, WE ARE UNABLE TO CONCLUDE IF THE DEVICE CAUSED OR CONTRIBUTED TO THE PTS SYMPTOMS, OR WHETHER THE PT TRULY HAD A MILD ANAPHYLACTIC REACTION. THUS, THIS EVENT IS BEING REPORTED.

Description of Event or Problem · 1

THE PT STARTED TREATMENTS WITH FIRST STAGE OF ALIGNERS, DELIVERED ON (B)(6) 2010. THE PT FIRST REPORTED SYMPTOMS ON (B)(6) 2011, BUT NOTED THE SYMPTOMS STARTED IN (B)(6) 2010. SYMPTOMS REPORTED: SWOLLEN TONGUE, RASH ALL OVER FACE, AND ON (B)(6) 2011, THE PT IDENTIFIED THAT IT WAS DIFFICULT TO SWALLOW. THE TREATING DOCTOR STOPPED THE TREATMENTS AT STAGE 12 OF 18. THE PT IDENTIFIED ALLERGIES TO ASPIRIN, JEWELRY, METALS, PENICILLIN, AND SEASONAL ALLERGIES. TO ALLEVIATE THE SYMPTOMS, THE PT REPORTEDLY TOOK A CORTISONE INJECTION, AND IS NOW SYMPTOM FREE. THE PT IS SCHEDULED TO SEE AN ALLERGIST. THE TREATING PHYSICIAN BELIEVES THAT THE PT COULD HAVE HAD A MILD ANAPHYLACTIC REACTION, BASED ON THE REPORTED BREATHING DIFFICULTIES. THUS, THIS EVENT IS BEING REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INVISALIGN SYSTEM SEQUENTIAL ALIGNERS - ORTHODONTIC DEVICE NXC ALIGN TECHNOLOGY, INC. INVISALIGN FULL 71634393

Patients

Seq Age Sex Outcome Treatment
1 70 YR Other